MGX
NASDAQ · Biotechnology
Metagenomi Therapeutics Inc
$0.79
+0.09 (+13.00%)
Performance
1D
+14.36%
1W
+9.56%
1M
-6.39%
3M
-35.16%
6M
-37.72%
1Y
-54.54%
YTD
-52.63%
Open$0.73
Previous Close$0.70
Day High$0.83
Day Low$0.73
52W High$2.01
52W Low$0.60
Volume—
Avg Volume199.1K
Market Cap26.99M
P/E Ratio—
EPS$-2.30
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$0.95
Below
SMA 200
$1.25
Below
RSI (14)
40.8
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
9 analysts
Price Target
+3,768.5% upside
Current
$0.79
$0.79
Target
$30.60
$30.60
$21.05
$30.60 avg
$40.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 23.10M | 20.33M | 24.43M |
| Net Income | -80,495,156 | -63,778,185 | -7,358,364 |
| Profit Margin | -348.5% | -331.1% | -30.1% |
| EBITDA | -83,085,279 | -69,487,644 | -8,749,975 |
| Free Cash Flow | — | — | -5,557,893 |
| Rev Growth | +13.6% | +13.6% | -4.6% |
| Debt/Equity | — | — | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |